Metabolites of the Ellagitannin Geraniin and Their Antioxidant Activities

 

 Permissions and Reprints

Abstract

Different types of ellagitannins are reported to have various biological activities, such as antioxidant, antiviral, and antitumor activities. However, there are few definitive studies on the absorption and metabolism of ellagitannins. This review compares the absorption and metabolism of ellagitannins, and the antioxidant properties of their metabolites in rats, with those of intact ellagitannins by means of in vitro and in vivo assays. We isolated 7 urinary and intestinal microbial metabolites in rats after the ingestion of geraniin, which is a typical ellagitannin isolated from Geranium thunbergii, an antidiarrheic remedy in Japan. The structures of these metabolites were determined to be dibenzopyran derivatives (1–7), using NMR and mass spectroscopic data. Four major metabolites (1–4) prepared by chemical synthesis were evaluated for their antioxidant activities by using 2,2-diphenyl-1-picrylhydrazyl radical scavenging and oxygen radical absorbance capacity (ORAC) methods. The metabolites exhibited more potent antioxidant activities in the ORAC assay than intact ellagitannins, such as geraniin and corilagin. Furthermore, plasma ORAC scores increased with increases in the plasma concentration of the metabolites after the oral administration of geraniin to rats. These findings suggest that these metabolites may contribute to the health benefits of ellagitannins as antioxidants in the body.

References

• 1 Okuda T, Yoshida T, Hatano T. Hydrolyzable tannins and related polyphenols.  Fortschr Chem Org Naturs. 1995;  66 1-117
  PubMedGoogle Scholar
• 2 Clifford M N, Scalbert A. Ellagitannins, occurrence in food, bioavailability and cancer prevention.  J Food Sci Agric. 2000;  80 1118-1125
  CrossrefPubMedGoogle Scholar
• 3 Okuda T, Yoshida T, Hatano T. Ellagitannins as active constituents of medicinal plants.  Planta Med. 1989;  55 117-122
  Article in Thieme ConnectPubMedGoogle Scholar
• 4 Nakashima H, Murakami T, Yamamoto N, Sakagami H, Tanuma S, Hatano T, Yoshida T, Okuda T. Inhibition of human immunodeficiency viral replication by tannins and related compounds.  Antiviral Res. 1992;  18 91-103
  CrossrefPubMedGoogle Scholar
• 5 Okuda T, Mori K, Hayatsu H. Inhibitory effect of tannins on direct-acting mutagens.  Chem Pharm Bull. 1984;  32 3755-3758
  CrossrefPubMedGoogle Scholar
• 6 Funatogawa K, Hayashi S, Shimomura H, Yoshida T, Hatano T, Ito H, Hirai Y. Antibacterial activity of hydrolyzable tannins derived from medicinal plants against Helicobacter pylori.  Microbiol Immunol. 2004;  48 251-261
  PubMedGoogle Scholar
• 7 Shiota S, Shimizu M, Mizusima T, Ito H, Hatano T, Yoshida T, Tsuchiya T. Restoration of effectiveness of β-lactams on methicillin-resistant Staphylococcus aureus by tellimagrandin I from rose red.  FEMS Microbiol Lett. 2000;  185 135-138
  PubMedGoogle Scholar
• 8 Ito H, Miyake M, Nishitani E, Mori K, Hatano T, Okuda T, Konoshima T, Takasaki M, Kozuka M, Mukainaka T, Tokuda H, Nishino H, Yoshida T. Anti-tumor promoting activity of polyphenols from Cowania mexicana and Coleogyne ramosissima.  Cancer Lett. 1999;  143 5-13
  CrossrefPubMedGoogle Scholar
• 9 Okabe S, Suganuma M, Imayoshi Y, Taniguchi S, Yoshida T, Fujiki H. New TNF-α releasing inhibitors, geraniin and corilagin, in leaves of Acer nikoense, Megusurino-ki.  Biol Pharm Bull. 2001;  24 1145-1148
  CrossrefPubMedGoogle Scholar
• 10 Doyle B, Griffiths L A. The metabolism of ellagic acid in the rat.  Xenobiotica. 1980;  10 247-256
  CrossrefPubMedGoogle Scholar
• 11 Cerda B, Llorach R, Ceron J J, Espin J C, Tomas-Barberan F A. Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice.  Eur J Nutr. 2003;  42 18-28
  CrossrefPubMedGoogle Scholar
• 12 Seeram N P, Lee R, Heber D. Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice.  Clin Chim Acta. 2004;  348 63-68
  CrossrefPubMedGoogle Scholar
• 13 Seeram N P, Henning S M, Zhang Y, Suchard M, Li Z, Heber D. Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours.  J Nutr. 2006;  136 2481-2485
  PubMedGoogle Scholar
• 14 Cerda B, Espin J C, Parra S, Martinez P, Tomas-Barberan F A. The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans.  Eur J Nutr. 2004;  43 205-220
  PubMedGoogle Scholar
• 15 Cerda B, Tomas-Barberan F A, Espin J C. Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability.  J Agric Food Chem. 2005;  53 227-235
  CrossrefPubMedGoogle Scholar
• 16 Ito H, Iguchi A, Hatano T. Identification of urinary and intestinal bacterial metabolites of ellagitannin geraniin in rats.  J Agric Food Chem. 2008;  56 393-400
  CrossrefPubMedGoogle Scholar
• 17 Pandey J, Jha A K, Hajela K. Synthesis and biological activities of some new dibenzopyranones and dibenzopyrans: search for potential oestrogen receptor agonists and antagonists.  Bioorg Med Chem. 2004;  12 2239-2249
  CrossrefPubMedGoogle Scholar
• 18 Ghosal S, Lata S, Kumar Y. Free radicals of shilajit humus.  Indian J Chem. 1995;  34B 591-595
  PubMedGoogle Scholar
• 19 Nawwar M A M, Souleman A M A. 3,4,8,9,10-Pentahydroxy-dibenzo[b,d]pyran-6-one from Tamarix nilotica.  Phytochemistry. 1984;  23 2966-2967
  CrossrefPubMedGoogle Scholar
• 20 Jeong S J, Kim N Y, Kim D H, Kang T H, Ahn N H, Miyamoto T, Higuchi R, Kim Y C. Hyaluronidase inhibitory active 6H-dibenzo[b,d]pyran-6-ones from the feces of Trogopterus xanthipes.  Planta Med. 2000;  66 76-77
  Article in Thieme ConnectPubMedGoogle Scholar
• 21 Lederer E. Chemistry and biochemistry of some mammalian secretions and excretions.  J Chem Soc. 1949;  2115-2125
  CrossrefPubMedGoogle Scholar
• 22 Pope G S. Isolation of two benzocoumarins from ‘clover stone a type of renal calculus found in sheep.  Biochem J. 1964;  93 474-477
  PubMedGoogle Scholar
• 23 Ghosal S, Reddy J P, Lal V K. Shilajit I: chemical constituents.  J Pharm Sci. 1976;  65 772-773
  CrossrefPubMedGoogle Scholar
• 24 Shirataki Y, Yoshida S, Toda S. Dibenzo-α-pyrons in fruits of Trapa natans.  Natural Medicines. 2000;  54 160
  PubMedGoogle Scholar
• 25 Okuda T, Yoshida T, Hatano T. Constituents of Geranium thunbergii Sieb. et Zucc. Part 12. Hydrated stereostructure and equilibration of geraniin.  J Chem Soc [Perkin I]. 1982;  9-14
  PubMedGoogle Scholar
• 26 Okuda T, Hatano T, Nitta H, Fujii R. Hydrolysable tannins having enantiomeric dehydrohexahydroxydiphenoyl group: revised structure of terchebin and structure of granatin B.  Tetrahedr Lett. 1980;  21 4361-4364
  CrossrefPubMedGoogle Scholar
• 27 Schmidt O T, Schulz J, Wurmb R. Über natürliche Gerbstoffe, XXXVI. Terchebin.  Justus Liebigs Ann Chem. 1967;  706 169-179
  CrossrefPubMedGoogle Scholar
• 28 Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. Polyphenols: food sources and bioavailability.  Am J Clin Nutr. 2004;  79 727-747
  PubMedGoogle Scholar
• 29 Hodgson J M, Morton L W, Puddey I B, Beilin L J, Croft K D. Gallic acid metabolites are markers of black tea intake in humans.  J Agric Food Chem. 2000;  48 2276-2280
  CrossrefPubMedGoogle Scholar
• 30 Yasuda T, Inaba A, Ohmori M, Endo T, Kubo S, Ohsawa K. Urinary metabolites of gallic acid in rats and their radical-scavenging effects on 1,1-diphenyl-2-picrylhydrazyl radical.  J Nat Prod. 2000;  63 1444-1446
  CrossrefPubMedGoogle Scholar
• 31 Baba S, Osakabe N, Natsume M, Terao J. Absorption and urinary excretion of procyanidin B2 [epicatechin-(4β-8)-epicatechin] in rats.  Free Radic Biol Med. 2002;  33 142-148
  CrossrefPubMedGoogle Scholar
• 32 Sano A, Yamakoshi J, Tokutake S, Tobe K, Kubota Y, Kikuchi M. Procyanidin B1 is detected in human serum after intake of proanthocyanidin-rich grape seed extract.  Biosci Biotechnol Biochem. 2003;  67 1140-1143
  CrossrefPubMedGoogle Scholar
• 33 Shoji T, Masumoto S, Moriichi N, Akiyama H, Kanda T, Ohtake Y, Goda Y. Apple procyanidin oligomers absorption in rats after oral administration: analysis of procyanidins in plasma using the porter method and high-performance liquid chromatography/tandem mass spectrometry.  J Agric Food Chem. 2006;  54 884-892
  CrossrefPubMedGoogle Scholar
• 34 Manach C, Morand C, Crespy V, Demigné C, Texier O, Régérat F, Rémésy C. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties.  FEBS Lett. 1998;  426 331-336
  CrossrefPubMedGoogle Scholar
• 35 Moon J, Tsushida T, Nakahara K, Terao J. Identification of quercetin 3-O-β-D-glucuronide as an antioxidative metabolite in rat plasma after oral administration of quercetin.  Free Radic Biol Med. 2001;  30 1274-1285
  CrossrefPubMedGoogle Scholar
• 36 Day A J, Bao Y, Morgan M R, Williamson G. Conjugation position of quercetin glucuronides and effect on biological activity.  Free Radic Biol Med. 2000;  29 1234-1243
  CrossrefPubMedGoogle Scholar
• 37 Shimoi K, Saka N, Nozawa R, Sato M, Amano I, Nakayama T, Kinae N. Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation.  Drug Metab Dispos. 2001;  29 1521-1524
  PubMedGoogle Scholar
• 38 Cao G, Alessio H M, Cutler R G. Oxygen-radical absorbance capacity assay for antioxidants.  Free Radic Biol Med. 1993;  14 303-311
  CrossrefPubMedGoogle Scholar
• 39 Ou B, Hampsch-Woodill M, Prior R L. Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe.  J Agric Food Chem. 2001;  49 4619-4626
  CrossrefPubMedGoogle Scholar
• 40 Azorin-Ortuno M, Urban C, Ceron J J, Tecles F, Gil-Izquierdo A, Pallares F J, Tomas-Barberan F A, Espin J C. Safety evaluation of an oak-flavored milk powder containing ellagitannins upon oral administration in the rat.  J Agric Food Chem. 2008;  56 2857-2865
  CrossrefPubMedGoogle Scholar
• 41 Cerda B, Ceron J J, Tomas-Barberan F A, Espin J C. Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic.  J Agric Food Chem. 2003;  51 3493-3501
  CrossrefPubMedGoogle Scholar
• 42 Gonzalez-Sarrias A, Azorin-Ortuno M, Yanez-Gascon M J, Tomas-Barberan F A, Garcia-Conesa M T, Espin J C. Dissimilar in vitro and in vivo effects of ellagic acid and its microbiota-derived metabolites, urolithins, on the cytochrome P450 1A1.  J Agric Food Chem. 2009;  57 5623-5632
  CrossrefPubMedGoogle Scholar
• 43 Gonzalez-Sarrias A, Gimenez-Bastida J A, Garcia-Conesa M T, Gomez-Sanchez M B, Garcia-Talavera N V, Gil-Izquierdo A, Sanchez-Alvarez C, Fontana-Compiano L O, Morga-Egea J P, Pastor-Quirante F A, Martinez-Diaz F, Tomas-Barberan F A, Espin J C. Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice.  Mol Nutr Food Res. 2010;  54 311-322
  CrossrefPubMedGoogle Scholar
• 44 Seeram N P, Aronson W J, Zhang Y, Henning S M, Moro A, Lee R P, Sartippour M, Harris D M, Rettig M, Suchard M A, Pantuck A J, Belldegrun A, Heber D. Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland.  J Agric Food Chem. 2007;  55 7732-7737
  CrossrefPubMedGoogle Scholar
• 45 Cerda B, Soto C, Albaladejo M D, Martinez P, Sanchez-Gascon F, Tomas-Barberan F, Espin J C. Pomegranate juice supplementation in chronic obstructive pulmonary disease: a 5-week randomized, double-blind, placebo-controlled trial.  Eur J Clin Nutr. 2006;  60 245-253
  CrossrefPubMedGoogle Scholar
• 46 Henning S M, Seeram N P, Zhang Y, Li L, Gao K, Lee R P, Wang D C, Zerlin A, Karp H, Thames G, Kotlerman J, Li Z, Heber D. Strawberry consumption is associated with increased antioxidant capacity in serum.  J Med Food. 2010;  13 116-122
  CrossrefPubMedGoogle Scholar
• 47 Seeram N P, Zhang Y, McKeever R, Henning S M, Lee R P, Suchard M A, Li Z, Chen S, Thames G, Zerlin A, Nguyen M, Wang D, Dreher M, Heber D. Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects.  J Med Food. 2008;  11 390-394
  CrossrefPubMedGoogle Scholar
• 48 Larrosa M, Gonzalez-Sarrias A, Yanez-Gascon M J, Selma M V, Azorin-Ortuno M, Toti S, Tomas-Barberan F, Dolara P, Espin J C. Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism.  J Nutr Biochem. 2010;  21 717-725
  CrossrefPubMedGoogle Scholar

Assoc. Prof. Hideyuki Ito

Division of Pharmaceutical Sciences
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

1-1-1 Tsushimanaka

Kita-ku

Okayama 700-8530

Japan

Phone: +81 8 62 51 79 37

Fax: +81 8 62 51 79 37

Email: hito@cc.okayama-u.ac.jp

• Supplementary Material